David B. Weiner insider trades: Inovio Pharmaceuticals (INO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 13, 2023 | INO | ↓ Sell | 5,833 | $1.15 | $7K | Direct | Mar 13, 2023 (0d) |
| Feb 27, 2023 | INO | ↓ Sell | 11,668 | $1.28 | $15K | Direct | Feb 28, 2023 (1d) |
| Aug 11, 2022 | INO | ↓ Sell | 11,875 | $2.66 | $32K | Direct | Aug 11, 2022 (0d) |
| May 16, 2022 | INO | ↓ Sell | 9,000 | $1.95 | $18K | Direct | May 17, 2022 (1d) |
| Mar 14, 2022 | INO | ↓ Sell | 4,083 | $3.20 | $13K | Direct | Mar 14, 2022 (0d) |
| Mar 9, 2022 | INO | ↓ Sell | 4,083 | $3.33 | $14K | Direct | Mar 9, 2022 (0d) |
| May 17, 2021 | INO | ↓ Sell | 3,045 | $6.62 | $20K | Direct | May 17, 2021 (0d) |
| Apr 21, 2021 | INO | ↓ Sell | 26,583 | $8.57 | $228K | Direct | Apr 21, 2021 (0d) |
| Mar 9, 2021 | INO | ↓ Sell | 7,000 | $9.39 | $66K | Direct | Mar 9, 2021 (0d) |
| Dec 15, 2020 | INO | ↓ Sell | 17,500 | $10.71 | $187K | Direct | Dec 17, 2020 (2d) |
| May 11, 2020 | INO | ↓ Sell | 2,404 | $11.84 | $28K | Direct | May 12, 2020 (1d) |
| Mar 12, 2020 | INO | ↓ Sell | 7,000 | $10.23 | $72K | Direct | Mar 12, 2020 (0d) |
| Mar 9, 2020 | INO | ↓ Sell | 3,500 | $18.00 | $63K | Direct | Mar 9, 2020 (0d) |
| Aug 1, 2019 | INO | ↓ Sell | 16,352 | $2.72 | $44K | Direct | Aug 2, 2019 (1d) |
| Apr 16, 2018 | INO | ↓ Sell | 9,000 | $4.91 | $44K | Direct | Apr 19, 2018 (3d) |
| May 25, 2017 | INO | ↓ Sell | 8,000 | $8.00 | $64K | Direct | May 26, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David B. Weiner's insider trades
David B. Weiner is a director at Inovio Pharmaceuticals (INO). Since May 25, 2017, David has reported no open-market purchases and 16 sales worth $914K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (27 filings), grants and awards (18 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.